한빛사논문 | BRIC

류민희 님의 논문 목록

울산대학교 의과대학

Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S- 1 with surgery and adjuvant durvalumab plus S- 1 for resectable locally advanced gastric cancer
- J. Immunother. Cancer, 01 February 2025 | https://doi.org/10.1136/jitc-2024-010635
- 2025-02
- 의약학
- 한빛사논문
Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancer
- J. Immunother. Cancer, 16 February 2025 | https://doi.org/10.1136/ jitc-2024-010455
- 2025-02
- 의약학
- 한빛사논문
Clinical and Biomarker Analysis of a Phase I/II Study of PDR001 plus Imatinib for Advanced Treatment-refractory Gastrointestinal Stromal Tumors
- Clin. Cancer Res., Apr 25 2024, | https://doi.org/10.1158/1078-0432.CCR-23-4065
- 2024-04
- 의약학
- 한빛사논문
Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study group
- Invest. New Drugs, 2012, DOI: 10.1007/s10637-012-9795-9
- 2012-04
- 생명과학
- 구.추천논문

저자논문